This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Regimmune Corporation. Active years: 2021.
Company Filing History:
1 out of 360 
1 out of 3 Years Active: 2021
Title: Junichiro Kishi: Innovator in Natural Killer T Cell Activation
Introduction
Junichiro Kishi is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of immunology, particularly in the activation of natural killer T cells. His work has implications for developing new therapeutic strategies in various diseases.
Latest Patents
Kishi holds a patent for a compound or salt thereof that acts as a natural killer T cell activator. The patent addresses the need for a novel compound capable of activating these cells, which play a crucial role in the immune response. The compound is represented by a specific formula, and it is designed to enhance the efficacy of natural killer T cell activating agents and pharmaceutical compositions.
Career Highlights
Throughout his career, Junichiro Kishi has worked with prestigious institutions, including Keio University and Regimmune Corporation. His research has focused on developing innovative solutions to enhance immune responses, particularly through the activation of natural killer T cells.
Collaborations
Kishi has collaborated with notable colleagues such as Toshihiko Aiba and Emi Kashiwabara. These partnerships have contributed to advancing research in the field of immunology and the development of new therapeutic agents.
Conclusion
Junichiro Kishi's work in natural killer T cell activation represents a significant advancement in immunological research. His innovative approach and collaborations have the potential to lead to new treatments for various diseases.